NRX Pharmaceuticals
NRXP
NRXP
34 hedge funds and large institutions have $25.1M invested in NRX Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 12 closing their positions.
Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
8
Closed
12
Calls
$1.34M
Puts
$1.06M
Net Calls
+$282K
Net Calls Change
+$987K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$15.3M |
| 2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$1.92M |
| 3 |
CH
3
CVI Holdings
Wilmington,
Delaware
|
$1.53M |
| 4 |
4
Renaissance Technologies
New York
|
$341K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$280K |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
2
Jane Street
New York
|
$0 |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.63M |
| 4 |
4
Squarepoint
New York
|
$0 |
| 5 |
SSA
5
Schonfeld Strategic Advisors
New York
|
$0 |
